GL1X · GenesisL1 explorer

MolNFT v1 · #61670 · protein

A potent peptidomimetic inhibitor of botulinum neurotoxin serotype a has a very different conformation than snap-25 substrate

3DSE · Botulinum neurotoxin type a: “A potent peptidomimetic inhibitor of botulinum neurotoxin serotype a has a very different conformation than…”. X-ray diffraction, 2 ligands (ZN, NI), 4 pockets (best druggability 0.66). MolNFT v1 #61670…

PDB
3DSE
Type
protein
Length
394 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Botulinum neurotoxin type a
EC
3.4.24.69
UniProt
A5HZZ9
Ligands
ZN, NI
Pockets
4 · best druggability 0.66

Structure

x-ray diffraction · 1 distinct chain · 32% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABotulinum neurotoxin type a (EC 3.4.24.69)protein39432% helix, 19% strandA5HZZ9

Ligands and binding sites

  • ZN · Zinc ion · metal · chains A
  • NI · Nickel (II) ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14390.660.7949empty
21170.380.7422empty
3670.380.7918empty
4500.330.7812empty

Compared structures

  • 3DSE · A potent peptidomimetic inhibitor of botulinum neurotoxin serotype A has a very different… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.